L Stein Selected Research

Co 2-6749

10/2000

Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Stein Research Topics

Disease

2	Neoplasms (Cancer) 05/2008 - 10/2000
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2008
1	Intraoperative Complications 01/2005
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2004
1	Tobacco Use Disorder (Nicotine Dependence) 01/2002
1	Myoma 08/2001
1	Depressive Disorder (Melancholia) 11/2000
1	Mental Disorders (Mental Disorder) 11/2000
1	Ataxia (Dyssynergia) 10/2000
1	Tuberculosis (Tuberculoses) 01/2000
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2000
1	Granuloma 01/2000

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 12/2004 - 01/2000
1	Antinuclear AntibodiesIBA 01/2014
1	ORALIT (ORS)IBA 05/2008
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 12/2004
1	Nicotine FDA Link 01/2002
1	SolventsIBA 11/2000
1	taxaneIBA 10/2000
1	Ethanol (Ethyl Alcohol)IBA 10/2000
1	Anti-Anxiety Agents (Anxiolytics)IBA 10/2000
1	Co 2-6749IBA 10/2000
1	AutoantibodiesIBA 01/2000
1	CytokinesIBA 01/2000

Therapy/Procedure

1	Length of Stay 01/2005
1	Uterine Artery Embolization 08/2001